<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00816231</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-14671</org_study_id>
    <nct_id>NCT00816231</nct_id>
  </id_info>
  <brief_title>Drug /Cue Interactions In Alcohol-Tobacco Comorbidity</brief_title>
  <official_title>Drug /Cue Interactions In Alcohol-Tobacco Comorbidity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how people react to different combinations of
      alcohol and nicotine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present project will improve and expand upon previously published work in several ways.
      First, Study 1 will assess reactivity to alcohol and smoking cues in the same session.
      Second, both studies will include within-subjects design factors to manipulate alcohol and
      nicotine intake, as well as cue types. Third, craving indices will represent three important
      response domains: subjective, physiological, and behavioral (e.g., Niaura et al., 1991).
      Fourth, each study will evaluate a range of drinkers and smokers, which will provide maximal
      information concerning influences on alcohol and smoking cue reactivity across various
      subject populations. The proposed studies are not only important from a theory development
      perspective, but they will provide an excellent foundation for future laboratory-based and
      clinical research.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 8, 2006</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Psychophysiological Reactivity Assessment</measure>
    <time_frame>approximately 5 weeks per participant</time_frame>
    <description>To assess cravings and psychophysiological reactivity elicited by alcohol, smoking, and neutral cues following acute intake of alcohol and nicotine among individuals across a broad range of alcohol and cigarette use patterns (Study 1).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alcohol Self-administration Assessment</measure>
    <time_frame>approximately 5 weeks per participant.</time_frame>
    <description>To assess alcohol self-administration upon exposure to alcohol or smoking-related cues following acute intake of alcohol, nicotine, or both drugs among individuals across a broad range of alcohol and cigarette use patterns (Study 2).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">244</enrollment>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>Alcohol and Nicotine Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Alcohol and Nicotine Drug/Cue Interactions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alcohol Only Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Alcohol Only Drug/Cue Interactions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nicotine Only Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nicotine Only Drug/Cue Interactions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo and Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Only Drug/Cue Interactions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tobacco</intervention_name>
    <description>Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving tobacco with brief summary at the end of the last session.</description>
    <arm_group_label>Alcohol and Nicotine Group</arm_group_label>
    <arm_group_label>Nicotine Only Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alcoholic Beverage</intervention_name>
    <description>Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving and alcohol with brief summary at the end of the last session.</description>
    <arm_group_label>Alcohol and Nicotine Group</arm_group_label>
    <arm_group_label>Alcohol Only Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving placebo with brief summary at the end of the last session.</description>
    <arm_group_label>Alcohol Only Group</arm_group_label>
    <arm_group_label>Nicotine Only Group</arm_group_label>
    <arm_group_label>Placebo and Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking persons who exhibit a range of alcohol consumption and smoking
             patterns.

          -  Signed written consent form.

        Exclusion Criteria:

          -  Females who are pregnant, nursing, or not using effective methods of birth control
             will be excluded from participating.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Drobes, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>H. Lee Moffitt Cancer Center and Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H. Lee Moffitt Cancer Center &amp; Research Institute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.moffitt.org/research--clinical-trials/clinical-trials</url>
    <description>Moffitt Cancer Center Clinical Trials website</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2008</study_first_submitted>
  <study_first_submitted_qc>December 31, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2009</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prevention Intervention</keyword>
  <keyword>Alcohol</keyword>
  <keyword>Tobacco</keyword>
  <keyword>Nicotine</keyword>
  <keyword>Craving</keyword>
  <keyword>Cue Reactivity</keyword>
  <keyword>Cross Cue Reactions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

